2019 International Congress

Monday, September 23, 2019

1:45pm-3:15pm

Differential effects of stem cell therapy in adult and middle-aged Parkinsonian mice

A. Nelke, S. García-López, A. Martínez-Serrano, M. Pérez Pereira (Madrid, Spain)

Gene and Cell-Based Therapies  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Differential enhancement of ERK, PKA and Ca2+ signaling in direct and indirect striatal neurons of Parkinsonian mice

LL. Mariani, S. Longueville, JA. Girault, D. Hervé, N. Gervasi (Paris, France)

Neuropharmacology  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Differential Gait Progression in idiopathic Parkinson’s disease with and without freezing of gait

A. Glover, L. Pillai, S. Doerhoff, T. Virmani (Little Rock, AR, USA)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Differential Gene Expression in Parkinson Disease and Chronic Traumatic Encephalopathy

FV. Delos Reyes (Quezon City, Philippines)

Genetics  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Digenic inheritance of WARS2 and CHRNA6 mutations in infantile parkinsonism

S. Galosi, S. Martinelli, V. Cordeddu, S. Fucile, C. Limatola, R. Carrozzo, M. Tartaglia, V. Leuzzi (Rome, Italy)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Digital biomarker sensor feature data reflect quality of life judgements (PDQ39) in recently diagnosed Parkinson’s disease patients

F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, H. Staunton, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, WY. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)

Other  ·  Agora 2 West, Level 2

1:45pm-3:15pm

Digital monitoring of Huntington’s disease with smartphone and smartwatch wearable technology: The Digital-HD study

R. Tortelli, T. Kilchenmann, F. Rodrigues, L. Byrne, A. Bamdadian, F. Lipsmeier, S. Schobel, M. Lindemann, E. Wild (London, United Kingdom)

Huntington’s Disease  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Directional versus omnidirectional Deep Brain Stimulation for Parkinson’s disease: Results of a prospective, blinded, multi‑center, single-arm crossover study

AS. Schnitzler, PM. Mir, MB. Brodsky, LV. Verhagen, SG. Groppa, BC. Cheeran, EK. Karst, FD. Defresne, JV. Vesper (Mainz, Germany)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3

1:45pm-3:15pm

Disease-in-a-dish: drug discovery using patient-derived stem cells in Hereditary Spastic Paraplegia

Y. Fan, G. Wali, R. Sutharsan, C. Sue, A. Mackay-Sim (Sydney, Australia)

Gene and Cell-Based Therapies  ·  Les Muses Terrace, Level 3

1:45pm-3:15pm

Dissecting the genetic complexity of Parkinson’s disease: a Parkin-GBA study

Z. Hanss, I. Boussaad, F. Massart, J. Jarazo, R. Krüger (Belvaux, Luxembourg)

Genetics  ·  Les Muses Terrace, Level 3